Hepatitis C and NAFLD/NASH
Discover the fascinating story of how hepatitis C went from an incurable disease to a treatable one, while NAFLD/NASH emerged as the leading indication for liver transplant in the developed world. Hear from Chris as he explains the history, challenges, and groundbreaking advancements in the field.In this clip
From this podcast
The Peter Attia Drive Podcast
#155 - Chris Sonnenday, M.D.: The history, challenges, and gift of organ transplantation
Related Questions
I have a question about liver transplants, specifically in the case of my daughter who had a liver transplant 11 years ago due to biliary atresia and has been doing amazingly well since then—without any issues or rejections. Her doctors call her the poster child for liver transplants, and her labs are all perfect. The only medication she is on is an anti-rejection medication, tacrolimus.
I have a question about liver transplants, specifically in the case of my daughter who had a liver transplant 11 years ago due to biliary atresia and has been doing amazingly well since then—without any issues or rejections. Her doctors call her the poster child for liver transplants, and her labs are all perfect. The only medication she is on is an anti-rejection medication, tacrolimus.
I have a question about liver transplants, specifically in the case of my daughter, who had a liver transplant 11 years ago due to biliary atresia and has been doing amazingly well since then—without any issues or rejections. Her doctors call her the poster child for liver transplants, and her labs are all perfect. The only medication she is on is an anti-rejection medication, tacrolimus.